endpts.com Open in urlscan Pro
108.138.36.38  Public Scan

Form analysis
1 forms found in the DOM

https://endpts.com/

<form action="https://endpts.com/">
  <input type="text" name="s" placeholder="Search">
  <button class="epn_ux_button epn_white epn_search_submit_button"></button>
</form>

Text Content

 * Channels
   * All News
   * In Focus
   * Special
   * AI
   * Bioregnum
   * Biotech Voices
   * Cell/Gene Tx
   * China
   * Coronavirus
   * Deals
   * Diagnostics
   * Discovery
   * FDA+
   * Financing
   * Health Tech
   * Law
   * Letters to the Editor
   * Manufacturing
   * Marketing
   * Opinion
   * Outsourcing
   * Peer Review
   * People
   * Pharma
   * R&D
   * Startups
   * Weekly
 * Webinars
 * Biopharma Jobs
 * More
   * Work at Endpoints
   * Letter to Editors
   * Editorial Standards
   * IPO Tracker
   * Webinars
   * Events
   * Sponsored Posts
   * Advertise
   * Privacy Policy
   * Endpoints Merch
   * About Us
   * Help


 * SIGN UP
 * LOG IN



Russell Glass, Headspace CEO
January 25, 2024 09:48 AM ESTUpdated 10:52 AM
Health Tech


HEAD­SPACE PLANS TO BE CASH-FLOW POS­I­TIVE IN THE FIRST QUAR­TER OF 2024


LYDIA RAMSEY PFLANZER

DEPUTY EDITOR

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up,
just click here.) 

SAN FRAN­CIS­CO — De­spite a $3 bil­lion val­u­a­tion, a Se­ries E round un­der
its belt and plans to be prof­itable, men­tal health start­up Head­space says it
isn’t plan­ning to make the leap to go pub­lic just yet.

In­stead, the com­pa­ny is look­ing to be­come cash-flow pos­i­tive in the first
quar­ter of this year, CEO Rus­sell Glass told End­points News in a
con­ver­sa­tion at Head­space’s San Fran­cis­co of­fice.


UNLOCK THIS ARTICLE INSTANTLY BY BECOMING A FREE SUBSCRIBER.

You’ll get access to free articles each month, plus you can customize what
newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS


ASSOCIATE DIRECTOR, OPERATIONS (LABORATORY SETTING)

ADIMAB, LLC

LEBANON, NH, USA

view job offer post your job now
TRENDING NOW


THREE BURN­ING 2024 QUES­TIONS FOR PFIZ­ER: WHAT TO DO IN WEIGHT LOSS, THE HUNT
FOR MEGABLOCK­BUSTERS, AND IN­TE­GRAT­ING ...


THE ACA­D­E­M­IC-EN­TRE­PRE­NEUR MOD­EL BUILT COM­PA­NIES AND MINT­ED
MIL­LION­AIRES. WHAT HAP­PENS WHEN ONE OF ITS EAR­LI­EST ...


VER­TEX'S NEXT CHAL­LENGE FOR PAIN PILL? CRACK­ING A MAR­KET DOM­I­NAT­ED BY
CHEAP OPI­OIDS


FDA COM­MIS­SION­ER ROBERT CALIFF HIGH­LIGHTS NEED FOR ‘CRE­ATIVE AP­PROACH­ES’
FOR RARE DIS­EASE THER­A­PIES


CRE­ATIVE AI GAINS STEAM AMONG PHAR­MA MAR­KETERS IN­CLUD­ING SANOFI,
NO­VAR­TIS, AL­THOUGH CON­CERNS ABOUND

sponsored


FUL­LY CHAR­AC­TER­IZ­ING A MAN­U­FAC­TUR­ING PROCESS IS CRIT­I­CAL FOR
AD­VANC­ING GENE THER­A­PIES AND PRI­OR­I­TIZ­ING PA­TIENT SAFE­TY

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas




LATEST

 * All News
 * Special
 * In Focus
   


CHANNELS

 * AI
 * Bioregnum
 * Biotech Voices
 * Cell/Gene Tx
 * China
 * Coronavirus
 * Deals
 * Diagnostics
 * Discovery
 * FDA+
 * Financing
 * Health Tech
 * Law
 * Letters to the Editor
 * Manufacturing
 * Marketing
 * Opinion
 * Outsourcing
 * Peer Review
 * People
 * Pharma
 * R&D
 * Startups
 * Weekly


MORE

 * Work at Endpoints
 * Letter to Editors
 * Editorial Standards
 * IPO Tracker
 * Events
 * Webinars
 * Sponsored Posts
 * Advertise
 * Endpoints Merch
 * About Us
 * Help


WORK IN BIOTECH

 * Endpoints Careers

© Endpoints News 2024

 * Help
 * Advertise
 * Privacy Policy
 * Business Model




LOG IN TO YOUR ACCOUNT


EMAIL




PASSWORD


Change my password Get a magic email link
LOG IN


REQUEST MAGIC LINK

If you're already an Endpoints subscriber, enter your email below for a magic
link that lets you log in quickly without using a password. Please note the
magic link is one-time use only and expires after 24 hours.


EMAIL


BACK
REQUEST


RESET PASSWORD

We'll e-mail you a link to set a new password. Please note this link is one-time
use only and is valid for only 24 hours.


EMAIL


BACK
RESET

SIGN UP FOR FREE TO READ A LIMITED NUMBER OF ARTICLES EACH MONTH.

ABOUT YOU







NEWSLETTER INTERESTS

PICK WHAT NEWSLETTERS GET DELIVERED TO YOUR INBOX EACH WEEK.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET



EARLY EDITION Daily at 7:15 AM ET



ENDPOINTS PHARMA Daily at 2 PM ET



BREAKING NEWS ALERTS 2-3 times a week



ENDPOINTS MARKETING RX Tue at 2 PM ET



ENDPOINTS FDA+ Wed at 2 PM ET



ENDPOINTS MANUFACTURING Thu at 2 PM ET



ENDPOINTS WEEKLY Sat at 6 AM ET



Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET



BREAKING NEWS ALERTS 2-3 times a week


INSTANT SIGN UP

Want unlimited access? Sign up for a premium subscription plan.